Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306

OBJECTIVES: Early tumor shrinkage (ETS) quantifies the objective response at the first assessment during systemic treatment. In metastatic colorectal cancer (mCRC), ETS gains relevance as an early available surrogate for patient survival. The aim of this study was to increase the predictive accuracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, Felix O., Heinemann, Volker, D’Anastasi, Melvin, Gesenhues, Alena B., Hesse, Nina, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Moehler, Markus, Kaiser, Florian, Heintges, Tobias, Kahl, Christoph, Kullmann, Frank, Scheithauer, Werner, Link, Hartmut, Modest, Dominik P., Stintzing, Sebastian, Holch, Julian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889429/
https://www.ncbi.nlm.nih.gov/pubmed/35976398
http://dx.doi.org/10.1007/s00330-022-09053-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889429/
https://www.ncbi.nlm.nih.gov/pubmed/35976398
http://dx.doi.org/10.1007/s00330-022-09053-2

Ejemplares similares